E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Effectiveness of anti-tuberculosis drugs in tuberculosis and HIV co-infected patients coming to tertiary health-care center in South Gujarat

Robinkumar Ratilal Patel, Parul Vadgama, Khyati Shamaliya.

Abstract
Background: Tuberculosis (TB) and human immunodeficiency virus (HIV) are major public health problems in most of the developing countries, including India. For developing TB, HIV infection is one of the strongest risk factors. The presentation and outcome of TB are affected by HIV infection.

Aims and Objectives: The objective is to study the type of TB, level of CD4 count, TB presentation in TB-HIV patients. Observation of anti-TB treatment, adverse drug reactions (ADR), and outcome of anti-TB treatment in patients with TB-HIV co-infection.

Materials and Methods: The present study is an observational, longitudinal, prospective, and single-center study of adult patients having TB-HIV co-infection. To evaluate the clinical course, outcome, and safety of anti-TB drugs, the selected patients were followed up during the study.

Results: In our study, 59 patients of TB-HIV co-infection on anti-TB treatment were observed. About 61% of the patients were male. Most of the patients had pulmonary TB (61%) and extra-pulmonary TB (EPTB) was found in 38.9% of patients. Tuberculous pleural effusion and cervical tuberculous lymphadenitis were the most common among EPTB cases. 93.2% of cases were drug-sensitive TB and 6.8% cases were drug-resistant TB. Low CD4 count <200 cell/cu.mm were observed in 61% of patients. All patients were treated according to RNTCP and National AIDS Control Organization guidelines. Majority of cases (67.8%) had no ADR. The most common ADR observed were gastritis and GIT symptoms (15.3%). Successful treatment was observed in 41 patients (69.5%), and interim outcomes were observed in 2 patients (3.4%). Three patients (5.1%) were transfer out, 6 patients (10.2%) were lost to follow-up, 7 patients (11.9%) died. Among patients who had CD4 count <200 cell/cu.mm, successfully treated patients were 61.1%, and among patients who had CD4 count ≥200 cell/cu.mm, 82.6% of patients were successfully treated.

Conclusion: Pulmonary TB is common than EPTB. In most of the patients, anti-TB drugs are effective, also well tolerated with ADRs in few patients. Most of ADRs are non-serious. The success rate of treatment is more among patients who had CD4 count ≥200 cell/cu.mm than among patients who had CD4 count <200 cell/cu.mm.

Key words: Adverse Drug Reactions; Anti-tuberculosis Drugs; Human Immunodeficiency Virus; Outcome; Safety; Tuberculosis-Human Immunodeficiency Virus Co-infection; Tuberculosis


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Robinkumar Ratilal Patel
Articles by Parul Vadgama
Articles by Khyati Shamaliya
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Patel RR, Vadgama P, Shamaliya K. Effectiveness of anti-tuberculosis drugs in tuberculosis and HIV co-infected patients coming to tertiary health-care center in South Gujarat. Natl J Physiol Pharm Pharmacol. 2023; 13(11): 2259-2264. doi:10.5455/njppp.2023.13.08418202329092023


Web Style

Patel RR, Vadgama P, Shamaliya K. Effectiveness of anti-tuberculosis drugs in tuberculosis and HIV co-infected patients coming to tertiary health-care center in South Gujarat. https://www.njppp.com/?mno=162761 [Access: February 02, 2024]. doi:10.5455/njppp.2023.13.08418202329092023


AMA (American Medical Association) Style

Patel RR, Vadgama P, Shamaliya K. Effectiveness of anti-tuberculosis drugs in tuberculosis and HIV co-infected patients coming to tertiary health-care center in South Gujarat. Natl J Physiol Pharm Pharmacol. 2023; 13(11): 2259-2264. doi:10.5455/njppp.2023.13.08418202329092023



Vancouver/ICMJE Style

Patel RR, Vadgama P, Shamaliya K. Effectiveness of anti-tuberculosis drugs in tuberculosis and HIV co-infected patients coming to tertiary health-care center in South Gujarat. Natl J Physiol Pharm Pharmacol. (2023), [cited February 02, 2024]; 13(11): 2259-2264. doi:10.5455/njppp.2023.13.08418202329092023



Harvard Style

Patel, R. R., Vadgama, . P. & Shamaliya, . K. (2023) Effectiveness of anti-tuberculosis drugs in tuberculosis and HIV co-infected patients coming to tertiary health-care center in South Gujarat. Natl J Physiol Pharm Pharmacol, 13 (11), 2259-2264. doi:10.5455/njppp.2023.13.08418202329092023



Turabian Style

Patel, Robinkumar Ratilal, Parul Vadgama, and Khyati Shamaliya. 2023. Effectiveness of anti-tuberculosis drugs in tuberculosis and HIV co-infected patients coming to tertiary health-care center in South Gujarat. National Journal of Physiology, Pharmacy and Pharmacology, 13 (11), 2259-2264. doi:10.5455/njppp.2023.13.08418202329092023



Chicago Style

Patel, Robinkumar Ratilal, Parul Vadgama, and Khyati Shamaliya. "Effectiveness of anti-tuberculosis drugs in tuberculosis and HIV co-infected patients coming to tertiary health-care center in South Gujarat." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 2259-2264. doi:10.5455/njppp.2023.13.08418202329092023



MLA (The Modern Language Association) Style

Patel, Robinkumar Ratilal, Parul Vadgama, and Khyati Shamaliya. "Effectiveness of anti-tuberculosis drugs in tuberculosis and HIV co-infected patients coming to tertiary health-care center in South Gujarat." National Journal of Physiology, Pharmacy and Pharmacology 13.11 (2023), 2259-2264. Print. doi:10.5455/njppp.2023.13.08418202329092023



APA (American Psychological Association) Style

Patel, R. R., Vadgama, . P. & Shamaliya, . K. (2023) Effectiveness of anti-tuberculosis drugs in tuberculosis and HIV co-infected patients coming to tertiary health-care center in South Gujarat. National Journal of Physiology, Pharmacy and Pharmacology, 13 (11), 2259-2264. doi:10.5455/njppp.2023.13.08418202329092023